Surveillance of Antimicrobial Consumption: Transfer international experiences to national level

Meeting Organizer

International Health Policy Program (IHPP), Thailand

United States Agency for International Development

Food and Agriculture Organization of the United Nations

World Health Organization South East Asia Regional Office

Contact Person : Dr Sunicha Chanvatik,

29 January 2018
09:00 - 17:30 hrs.
Venue : LOTUS SUITE 10

Closed Meeting Invitation Only


The use of antimicrobials accelerates the development and the spread of antimicrobial resistances (AMR), which contributes to the ineffective use of antimicrobial in humans and animals and finally poses a serious risk for public health. Monitoring antimicrobial consumption has been recognised as a key entry point for optimizing and rational use of antimicrobials which will contribute to a decrease in AMR. The World Health Organization (WHO), in cooperation with the Food and Agriculture Organization of United Nations (FAO) and the World Organization for Animal Health (OIE), has recommended to the countries to establish a system for monitoring antimicrobial consumption [ ] in line with Global Action Plan on AMR (GAP). In addition, the Political Declaration of the High-Level Meeting of the UNGA on AMR in September 2016 which calls for “Improve surveillance and monitoring of AMR and the use of antimicrobials to inform policies” [ ] puts pressure on developing countries to develop surveillance system and ensure a timely use for policy decision. In addition, evidence from the surveillance of antimicrobial consumption (SAC) is essential for evaluation progresses in implementing the policy on optimizing use of antimicrobial. The WHO established a manual for WHO methodology for a global programme on surveillance of antimicrobial consumption, as well as the OIE has recently reported on the use of antimicrobial agents in animals, which aimed countries to compile details quantitative data of antimicrobial consumption. SAC has been well established in a number of high income countries, in particular in European Union, SAC structure and reporting is guided by ESAC and ESVAC using standard methodology allowing comparisons between countries. However, there is no such monitoring system in developing countries.


1. To share and discuss different methods used by countries for monitoring antimicrobial consumption in humans and animals • Sources of data: national sales data, national insurance reimbursement data, use of data from certain hospitals, data on antimicrobial importation • Quality and scope of data of antimicrobial • Compilation total annual local production, importation and exportation of food animals for the estimate of Population Correcting Unit (PCU) • Strengths and weakness of different methods and data sources. 2. To share experiences on how SAC has been established and used for policy making • Micro-level clinical decision • Macro-level policy monitoring • Challenges 3. How to move towards to a “One Health” approach for an integrated surveillance systems and reports of Antimicrobial Consumption and Resistance Analysis in human/ animal/ food/ agriculture and environment sectors 4. To discuss the applicability of experiences of developed countries to developing countries context 5. To discuss the next steps in developing the SAC in member countries